The present invention is concerned with substituted azole derivatives thatselectively modulate, regulate, and/or inhibit signal transduction mediated bycertain native and/or mutant proteine kinases implicated in a variety of humanandanimal diseases such as cell proliferative, metabolic, allergic, anddegenerativedisorders. In particular, several of these compounds are potent and selectiveFlt-3inhibitors or/and syk inhibitors. In one embodiment, the invention provides acompound of formula (I):(see formula I)